Percheron Therapeutics, previously known as Antisense, has appointed biotech executive Dr Michael Baker as its new chief executive officer and managing director, as current CEO Dr James Garner prepares to leave the role for an overseas opportunity. …
Percheron turns to former Arovella chief Michael Baker for next phase of HMBD 002 development
August 10, 2026 Latest NewsAustralian BiotechBioPharmaDispatch Executive
Latest Video
New Stories
-
Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product
August 13, 2026 - - Latest News -
Survey exposes deep gaps in neurological care across Australia
August 13, 2026 - - Latest News -
US childhood vaccine move away from combinations contrasts with Australia’s national schedule
August 12, 2026 - - Latest News -
Former minister joins DBG Health board as company broadens healthcare ambition
August 12, 2026 - - Latest News -
A sage appointment that puts DBG Health another step closer to a serious understanding of decision-making
August 12, 2026 - - Latest News -
Patients welcome the timely PBS listing of rare cancer therapy
August 12, 2026 - - Latest News -
How education exposes the moral and ethical limits of our health decision-making
August 11, 2026 - - Latest News